Bohdan Chopko, MD, PhD
Focus on implant material design in embolic coils, stents and polymer materials
Silver Bullet is developing OrthoFuzIon™, an antimicrobial coating based on proprietary silver ionization technology designed to prevent contaminations associated with medical device implants.
There is a significant clinical need to prevent bacteria from contaminating patients upon medical device implantation
The CMS “Bundled Payments for Care Improvement” (BPCI) may be a dramatic driving force for market adoption of OrthoFuzIon™ and Galvanis Technology
Over 10 years of development, testing, and animal trials have enabled technology perfection
Paul Chirico, President & CEO
Silver Bullet Therapeutics is committed to providing innovative medical devices that meet regulatory and customer requirements while maintaining an effective quality system. This is through teamwork and operational excellence that challenge the norm of medical care.
About Silver Bullet
NOT FOR FOR SALE IN UNITED STATES OF AMERICA
NOT FDA CLEARED
SILVER BULLET THERAPEUTICS QUALITY POLICY